Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 3 2Phase NA 1Phase 4 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Multiple Myeloma 169Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Recurrence 28Leukemia 24Vomiting 23Neoplasms, Plasma Cell 20Lymphoma 18Neoplasms 16Nausea 13Burkitt Lymphoma 11Prostatic Neoplasms 8Immunoglobulin Light-chain Amyloidosis 7Carcinoma, Non-Small-Cell Lung 6Lymphoma, Follicular 5Lung Neoplasms 5Hodgkin Disease 5Ovarian Neoplasms 4Neoplasm Metastasis 4Lymphoma, Non-Hodgkin 4Leukemia, Biphenotypic, Acute 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Small Cell Lung Carcinoma 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Paraproteinemias 3Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Fallopian Tube Neoplasms 3

Interventions

pegaspargase 4Oxaliplatin 3Gemcitabine 3Methotrexate 2Etoposide 2Early Intervention, Educational 2Doxorubicin 2Dexamethasone 2sugemalimab 1ferrous sulfate 1ferric gluconate 1Vincristine 1Thalidomide 1Sucrose 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Psychiatric Rehabilitation 1Prednisone 1Pharmacogenomic Testing 1Ketamine 1Drug Therapy 1Darbepoetin alfa 1Cyclophosphamide 1Ciprofloxacin 1Asian ginseng 1Amoxicillin-Potassium Clavulanate Combination 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Extranodal NK-T-Cell × Dexamethasone × Clear all
NCT02631239 2021-08-25

MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma

Ruijin Hospital

Phase 3 Unknown
256 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT02085655 2021-03-15

PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma

Sun Yat-sen University

Phase 3 Unknown
264 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡